Journey Thru the GI Tract—Practical Pearls for the Healthcare Professional
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Your Mouth on Meth
Common Ingredients in Meth Manufacturing The com mon ingredients used in making methamp hetamine and listed below are very acidic: ■ Antifreeze ■ Battery acid ■ Drain cleaner ■ Hydrochloric acid ■ Lantern fuel ■ Lye ■ Muriatic acid ■ Paint thinner ■ Red phosphorus found in the strips on match boxes ■ Over-the-counter cold medicines that contain ephedrine Mix these together and you have some caustic stuff. Meth users can go from having healthy teeth and a sparkling smile to losing their teeth in a very short time period. For most, dentures D M are the only option. D , n e l l A These dangerous chemicals can also make you h t i feel like there are bugs under your skin, causing d u J you to scratch yourself to the point that you : o t o have bleeding sores on your face, arms and legs. h p Health Care for the Homeless Clinicians' Network Your Mouth on P O Box 60427 | Nashville, TN 37206 Phone: 615 226-2292 Meth [email protected] | www.nhchc.org One Big Problem What You Can Do What You Need to Know While methamphetamine is very damaging to ■ Do not use methamphetamine or other the body and brain, it also destroys teeth. An drugs. unhealthy, unattractive mouth makes it difficult ■ If you’re already using, call the agency Meth, Speed, Ice, Chalk, Crank, Fire, Glass and to feel good about your appearance, socialize below for help getting off drugs. Crysta l are street names for the drug and find a job. ■ Instead of drinking sodas, drink plenty of metha mphetamine. -
Related Osteonecrosis of the Jaw in Patients with Sjögren's Syndrome
Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-024655 on 13 February 2019. Downloaded from Increased risk of bisphosphonate- related osteonecrosis of the jaw in patients with Sjögren’s syndrome: nationwide population-based cohort study Min-Tser Liao,1,2 Wu-Chien Chien,3,4,5 Jen-Chun Wang,6 Chi-Hsiang Chung,3,4,7 Shi-Jye Chu,8 Shih-Hung Tsai6,9 To cite: Liao M-T, Chien W-C, ABSTRACT Strengths and limitations of this study Wang J-C, et al. Increased Objective The aim of this study was to explore whether risk of bisphosphonate- patients with Sjögren’s syndrome (SS) were susceptible ► The strength of our study is its population-based related osteonecrosis of to bisphosphonate (BP)-related osteonecrosis of the jaw the jaw in patients with cohort design with a large number of patients and (BRONJ) after tooth extraction in the entire population of Sjögren’s syndrome: long-term follow-up, which aims to evaluate the Taiwan. nationwide population-based association between Sjögren’s syndrome and os- Design A nationwide population-based retrospective cohort study. BMJ Open teonecrosis of the jaw (ONJ) after tooth extraction. 2019;9:e024655. doi:10.1136/ cohort study. ► The National Health Insurance Research Database Setting Data were extracted from Taiwan’s National bmjopen-2018-024655 registry could not provide detailed information re- Health Insurance Research Database (NHIRD). Prepublication history and garding laboratory results, family histories and ► Methodology Medical conditions for both the study and additional material for this health-related lifestyle factors. control group were categorised using the International paper are available online. -
• Acute Pericoronitis • End-Stage Renal Disease • Acute Infectious Stomatitis an Acute Apical Abscess Should Not Be a Contraindication to Extraction
• acute pericoronitis • end-stage renal disease • acute infectious stomatitis An acute apical abscess should not be a contraindication to extraction. It has been shown that these infections can resolve very quickly when the affected tooth is removed. However, it may be diffi - cult to extract such a tooth, either because the patient is unable to open sufficiently wide enough or because adequate local anesthesia cannot be obtained. There are few true contraindications to the extraction of teeth. Note: In some instances, the pa - tients’ health may be so compromised that they cannot withstand the surgical procedure. Examples of contraindications include: • End-stage renal disease • Severe uncontrolled metabolic diseases (i.e., uncontrolled diabetes mellitus) • Advanced cardiac conditions (unstable angina) • Patients with leukemia and lymphoma should be treated before extraction of teeth • Patients with hemophilia or platelet disorders should be treated before extraction of teeth • Patients with a history of head and neck cancer need to be treated with care because even minor surgery can lead to osteoradionecrosis. Note: These patients are often treated with hyperbaric oxygen therapy prior to (20 sessions) and following extractions (10 sessions). • Pericoronitis: infection of the soft tissues around a partially erupted mandibular third molar Note: This infection should be treated prior to removal of the maxillary third molar. • Acute infectious stomatitis and malignant disease are relative contraindications • Treatment with IV bisphosphonates increases the risk of osteonecrosis of the jaw Note: Causes of excessive bleeding after dental extractions include: injury to the inferior alveolar artery during extraction of a mandibular tooth (usually the third molar), a muscular arteriolar bleed from a flap procedure, or bleeding related to the patient’s history (i.e., patients who are on warfarin or drugs for platelet inhibition, patients who have hemophilia or von Willebrand disease, or who have chronic liver insufficiency).. -
Oral Manifestations in Drug Users: a Review
J Clin Exp Dent. 2020;12(2):e193-200. Oral manifestations in drug users Journal section: Oral Medicine and Pathology doi:10.4317/jced.55928 Publication Types: Review https://doi.org/10.4317/jced.55928 Oral manifestations in drug users: A review Federico Cossa 1, Alessia Piastra 2, Mª Gracia Sarrion-Pérez 3, Leticia Bagán 4 1 Student of the master of Implantology at the Universidad Europea de Valencia. Graduated in Dentistry at the Universidad Europea de Valencia 2 Student of the master of Endodontics at the University of Valencia. Graduated in Dentistry at the Universidad Europea de Valencia 3 PhD, Associate Professor. Faculty of Health Sciences. Department of Dentistry. European University of Valencia. Spain 4 PhD, Titular professor. Faculty of Health Sciences. Department of Dentistry. European University of Valencia. Spain Correspondence: Universidad Europea de Valencia Paseo Alameda, 7 46010 – Valencia, Spain [email protected] Cossa F, Piastra A, Sarrion-Pérez MG, Bagán L. Oral manifestations in drug users: A review. J Clin Exp Dent. 2020;12(2):e193-200. http://www.medicinaoral.com/odo/volumenes/v12i2/jcedv12i2p193.pdf Received: 24/06/2019 Accepted: 08/01/2020 Article Number: 55928 http://www.medicinaoral.com/odo/indice.htm © Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488 eMail: [email protected] Indexed in: Pubmed Pubmed Central® (PMC) Scopus DOI® System Abstract Background: In the dental environment there is not much talk about the oral manifestations resulting from the use of drugs, because in general the issue of drugs is a very difficult subject to deal with. Therefore, the objective of this work is to understand what are the most obvious manifestations in the oral cavity and as the dentist can detect them. -
Methamphetamine Abuse and “Meth Mouth” in Europe
Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20 (2):e205-10. Meth Mouth in EU Journal section: Medically compromised patients in Dentistry doi:10.4317/medoral.20204 Publication Types: Review http://dx.doi.org/doi:10.4317/medoral.20204 Methamphetamine abuse and “meth mouth” in Europe Carlo De-Carolis 1, Geraldine-A. Boyd 2, Luca Mancinelli 3, Stefano Pagano 1, Stefano Eramo 1 1 DDS. Department of Surgical and Biomedical Sciences-School of Dentistry- University of Perugia, Italy 2 Language Centre (CLA), University of Perugia, Italy 3 Geology Department, University of Dublin, Ireland Correspondence: School of Dentistry, University of Perugia Strada vicinale delle corse 60180 Perugia, Italy De-Carolis C, Boyd GA, Mancinelli L, Pagano S, Eramo S. Methamphet- [email protected] amine abuse and “meth mouth” in Europe. Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20 (2):e205-10. http://www.medicinaoral.com/medoralfree01/v20i2/medoralv20i2p205.pdf Received: 28/05/2014 Article Number: 20204 http://www.medicinaoral.com/ Accepted: 16/10/2014 © Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946 eMail: [email protected] Indexed in: Science Citation Index Expanded Journal Citation Reports Index Medicus, MEDLINE, PubMed Scopus, Embase and Emcare Indice Médico Español Abstract With easy chemical synthesis from its precursor, methamphetamine (MA) is now widespread in many countries. The abuse of methamphetamine is associated with several negative effects on health, because MA is a neurotoxin and a dangerous central nervous system stimulant. It changes levels of neurotransmitters in the brain, releasing dopamine and inhibiting nor epinephrine uptake which increases sympathetic nervous system activity and can lead to cardiac arrhythmia, hypertension and tachypnea. -
PATIENT FACT SHEET Osteonecrosis of the Jaw
PATIENT FACT SHEET Osteonecrosis of the Jaw Osteonecrosis of the jaw (ONJ) is a condition where While there is a very low risk of ONJ occurring in people the jawbone is exposed and not covered by gums; a taking any of these medications, the risk may be slightly condition of poor healing. Bone weakens and dies. higher in people who require invasive dental procedures, There is no test to measure ONJ risk, but some factors such as a dental extraction or dental implant, if they also are known to raise this risk in very rare circumstances. take bisphosphonates. CONDITION Bisphosphonates, like alendronate (Fosamax), Patients who receive intravenous (injection into vein) DESCRIPTION risedronate (Actonel and Atelvia), ibandronate (Boniva), bisphosphonates as part of their cancer treatment are zoledronic acid (Reclast) and denosumab (Prolia), may at higher risk for ONJ than those who receive the much raise ONJ risk. This may be due to loss of bone’s ability to lower doses for osteoporosis treatment. Older age, repair itself, a drop in blood vessel formation or infection. diabetes, gum disease and smoking also raise ONJ risk. People with ONJ may experience pain, soft tissue swelling and drainage in the mouth, and an exposed jawbone for eight weeks or longer. Other possible signs are bad breath, loose teeth and signs of infection on gums. SIGNS/ SYMPTOMS People with osteoporosis who develop ONJ receive A rheumatologist has experience in treating osteoporosis conservative treatments, such as oral rinses, with antiresorptive medications and managing the risk antibiotics and oral analgesics to ease pain. These of osteonecrosis of the jaw. -
Risk Factors for Temporomandibular Disorders Among Amphetamine Users in Indonesia
Pesquisa Brasileira em Odontopediatria e Clínica Integrada 2019; 19:e5261 DOI: http://doi.org/10.4034/PBOCI.2019.191.142 ISSN 1519-0501 ORIGINAL ARTICLE Risk Factors for Temporomandibular Disorders among Amphetamine Users in Indonesia Inge Paramitha1, Ira Tanti2, Laura S. Himawan3 1Department of Prosthodontics, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia. 0000-0002-0072-379X 2Department of Prosthodontics, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia. 0000-0002-0119-3153 2Department of Prosthodontics, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia. 0000-0002-6331-5160 Author to whom correspondence should be addressed: Dr. Ira Tanti, Department of Prosthodontics, Faculty of Dentistry, Universitas Indonesia, Jalan Salemba Raya no.4, Jakarta Pusat, Jakarta 10430, Indonesia. Phone: +62 8161164801. E-mail: [email protected]. Academic Editors: Alessandro Leite Cavalcanti and Wilton Wilney Nascimento Padilha Received: 03 April 2019 / Accepted: 09 September 2019 / Published: 24 September 2019 Abstract Objective: To determine the possible risk factors for temporomandibular disorders (TMD) among amphetamine users in Indonesia. Material and Methods: This cross-sectional study involved 152 male amphetamine users, aged 18-45 years, who were undergoing rehabilitation. Data were obtained from medical records, questionnaires, and clinical examinations. Data obtained from medical records included age, gender, duration of amphetamine use, duration of rehabilitation, and psychiatric status. Collected data were analyzed using the Chi-square and logistic regression tests to identify correlations between TMD and bruxism, oral habits, tooth wear, duration of amphetamine abused, and duration of rehabilitation. Results: TMD was found in 84.2% of amphetamine users, with clicking being the most frequently reported sign (72.4%). Tooth wear (72.4%), oral habits (60.5%), and bruxism (56.6%) were also frequently found. -
Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies
International Journal of Molecular Sciences Review Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies Lucía Melguizo-Rodríguez 1,2, Victor J. Costela-Ruiz 2,3, Francisco Javier Manzano-Moreno 2,4, Concepción Ruiz 2,3,5,* and Rebeca Illescas-Montes 2,3 1 Biomedical Group (BIO277), Department of Nursing, Faculty of Health Sciences (Ceuta), University of Granada, 51001 Granada, Spain; [email protected] 2 Instituto Investigación Biosanitaria, ibs.Granada, 18012 Granada, Spain; [email protected] (V.J.C.-R.); [email protected] (F.J.M.-M.); [email protected] (R.I.-M.) 3 Biomedical Group (BIO277), Department of Nursing, Faculty of Health Sciences, University of Granada, 18016 Granada, Spain 4 Biomedical Group (BIO277), Department of Stomatology, School of Dentistry, University of Granada, 18071 Granada, Spain 5 Institute of Neuroscience, University of Granada, 18016 Granada, Spain * Correspondence: [email protected]; Tel.: +34-958243497 Received: 17 June 2020; Accepted: 15 July 2020; Published: 21 July 2020 Abstract: Saliva is a highly versatile biological fluid that is easy to gather in a non-invasive manner—and the results of its analysis complement clinical and histopathological findings in the diagnosis of multiple diseases. The objective of this review was to offer an update on the contribution of salivary biomarkers to the diagnosis and prognosis of diseases of the oral cavity, including oral lichen planus, periodontitis, Sjögren’s syndrome, oral leukoplakia, peri-implantitis, and medication-related osteonecrosis of the jaw. Salivary biomarkers such as interleukins, growth factors, enzymes, and other biomolecules have proven useful in the diagnosis and follow-up of these diseases, facilitating the early evaluation of malignization risk and the monitoring of disease progression and response to treatment. -
Oral and Maxillo-Facial Manifestations of Systemic Diseases: an Overview
medicina Review Oral and Maxillo-Facial Manifestations of Systemic Diseases: An Overview Saverio Capodiferro *,† , Luisa Limongelli *,† and Gianfranco Favia Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Piazza G. Cesare, 11, 70124 Bari, Italy; [email protected] * Correspondence: [email protected] (S.C.); [email protected] (L.L.) † These authors contributed equally to the paper. Abstract: Many systemic (infective, genetic, autoimmune, neoplastic) diseases may involve the oral cavity and, more generally, the soft and hard tissues of the head and neck as primary or secondary localization. Primary onset in the oral cavity of both pediatric and adult diseases usually represents a true challenge for clinicians; their precocious detection is often difficult and requires a wide knowledge but surely results in the early diagnosis and therapy onset with an overall better prognosis and clinical outcomes. In the current paper, as for the topic of the current Special Issue, the authors present an overview on the most frequent clinical manifestations at the oral and maxillo-facial district of systemic disease. Keywords: oral cavity; head and neck; systemic disease; oral signs of systemic diseases; early diagnosis; differential diagnosis Citation: Capodiferro, S.; Limongelli, 1. Introduction L.; Favia, G. Oral and Maxillo-Facial Oral and maxillo-facial manifestations of systemic diseases represent an extensive and Manifestations of Systemic Diseases: fascinating study, which is mainly based on the knowledge that many signs and symptoms An Overview. Medicina 2021, 57, 271. as numerous systemic disorders may first present as or may be identified by head and https://doi.org/10.3390/ neck tissue changes. -
Medication Related Osteonecrosis of Jaw
Jemds.com Case Report Medication Related Osteonecrosis of Jaw Prasanthi Sitaraman1, Arvind Muthukrishnan2 1Department of Oral Medicine and Radiology, Saveetha Dental College, Tamilnadu, India. 2Department of Oral Medicine and Radiology, Saveetha Dental College, Chennai, Tamilnadu, India. PRESENTATION OF CASE A 41 year old female patient reported with the complaint of pain in the right posterior Corresponding Author: mandibular region for the past 5 months. History revealed that patient was diagnosed Dr. Prasanthi Sitaraman. with breast cancer before 4 years following which she underwent mastectomy, Department of Oral Medicine and radiotherapy and chemotherapy. PET / CT taken post chemotherapy showed bone Radiology, Saveetha Dental College, Saveetha Institute of Medical and Technical metastasis to the lumbar spine for which she was prescribed I.V. zoledronic acid to Sciences (SIMATS), 162, Poonamallee High be administered every 3 months. Patient was under I.V. zoledronic acid for a total of Road, Chennai - 600077, Tamilnadu, India. 36 months. E-mail: [email protected] Patient underwent surgery for extraction of impacted lower third molar before 7 months. The extraction site did not completely heal following which the tooth DOI: 10.14260/jemds/2020/602 adjacent to the extraction site became mobile. The mobile tooth was also extracted before 5 months following which she developed pain and swelling in the region. How to Cite This Article: Patient was diagnosed with osteoradionecrosis and underwent curettage and Sitaraman P, Muthukrishnan A. Medication related osteonecrosis of jaw. J Evolution antiseptic dressing for 2 months. However, there was no reduction in pain. Pain was Med Dent Sci 2020;9(37):2770-2772, DOI: gradual in onset, continuous, gnawing, in the extraction site, aggravated by 10.14260/jemds/2020/602 mastication and relieved by medication. -
Studies of Synthetic Particles and Nerve Endings on Mass
STUDIES OF SYNTHETIC PARTICLES AND NERVE ENDINGS ON MASS TRANSPORT AND KINETICS AND INHIBITION OF THE DEGLYCOSYLATED DOPAMINE TRANSPORTER By VERONICA MANLING CHIU A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY WASHINGTON STATE UNIVERSITY Department of Chemistry May 2012 To the Faculty of Washington State University: The members of the Committee appointed to examine the dissertation of VERONICA MANLING CHIU find it satisfactory and recommend that it be accepted. __________________________________ James O. Schenk, Ph.D., Chair ___________________________________ Herbert H. Hill, Jr., Ph.D. ___________________________________ Chulhee Kang, Ph.D. ___________________________________ Barbara A. Sorg, Ph.D. ii ACKNKOWLEDGEMENTS I would like to start by thanking my committee, Drs. Jim Schenk, Herb Hill, Chulhee Kang, and Barb Sorg for their support, encouragement, and guidance. I am especially grateful to my mentor as well as my friend, Dr. Jim Schenk, for the infinite support, patience, and encouragement. Jim, you allowed me to learn, think and find answers on my own, but at the same time you provided help whenever I needed it. You also encouraged me to believe who I am. You taught me how to write a scientific paper and allowed me to write in my own words. You also provided me much help with giving presentations, which I am still learning about. In addition to science knowledge, I learned a lot from you on cooking, food, American culture, and arts. I really enjoyed the time when we gathered and shared food, and of course, your food is always so tasty. I know I am going to miss it! I also enjoyed our talks, and I never met a person who has as much knowledge as you do. -
SAID 2013 Literature Review
2013 SAID Literature Review – Annual Seminar Philadelphia, PA 2013 ANNUAL SEMINAR PHILADELPHIA, PA Special Care Advocates in Dentistry 2013 Lit. Review (SAID’s Search of Dental Literature Published in Calendar Year 2012*) Compiled by: Dr. Robert G. Henry Dr. Douglas Veazey Special Acknowledgement to Ms. Sandy Challman who provided computer support, literature searches, and collecting and compiling the final articles which are seen here. Without her help and support this review would not have been possible. 1 2013 SAID Literature Review – Annual Seminar Philadelphia, PA Recent journal articles related to oral health care for people with mental and physical disabilities. Search Program = PubMed Database = Medline Journal Subset = Dental Publication Timeframe = Calendar Year 2012* Language = English SAID Search-Term Results = 2,933 Initial Selection Result = 682 articles Final Selection Result = 144 articles SAID Search-Terms Employed: 1. Intellectual disability 21. Protective devices 2. Mental retardation 22. Moderate sedation 3. Mental deficiency 23. Conscious sedation 4. Mental disorders 24. Analgesia 5. Mental health 25. Anesthesia 6. Mental illness 26. Dental anxiety 7. Dental care for disabled 27. Nitrous oxide 8. Dental care for chronically ill 28. Gingival hyperplasia 9. Self-mutilation 29. Gingival hypertrophy 10. Disabled 30. Glossectomy 11. Behavior management 31. Sialorrhea 12. Behavior modification 32. Bruxism 13. Behavior therapy 33. Deglutition disorders 14. Cognitive therapy 34. Community dentistry 15. Down syndrome 35. State dentistry 16. Cerebral palsy 36. Gagging 17. Epilepsy 37. Substance abuse 18. Enteral nutrition 38. Syndromes 19. Physical restraint 39. Tooth brushing 20. Immobilization 40. Pharmaceutical preparations Program: EndNote X3 used to organize search and provide abstract.